|
Status |
Public on Jan 25, 2019 |
Title |
HiBEC_Ctrl3 |
Sample type |
SRA |
|
|
Source name |
Biliary Epithelial Cells
|
Organism |
Homo sapiens |
Characteristics |
cell line: Human Intrahepatic Biliary Epithelial Cells (HIBEC) passage: P4-6 agent: Vehicle (Control)
|
Treatment protocol |
Recombinat human TGF-beta at 10ng/ml for 48 hours
|
Growth protocol |
Cells grown in H69 media used for cholangiocyte cell lines
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen Kit RNA libraries were prepared for sequencing using standard Illumina protocols
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 3000 |
|
|
Description |
3_HiBEC_Ctrl3
|
Data processing |
TopHat v2.1.0 for alignment FeatureCounts to quantify expression edgeR for defining differentially expressed genes Genome_build: GRCh38 (hg38) Supplementary_files_format_and_content: tsv format containing edgeR differential expression results along with RPKM values
|
|
|
Submission date |
Jan 24, 2019 |
Last update date |
Jan 26, 2019 |
Contact name |
Aditya Bhagwate |
E-mail(s) |
bhagwate.adityavijay@mayo.edu
|
Organization name |
Mayo Clinic
|
Street address |
200 1st Street SW
|
City |
Rochester |
State/province |
MN |
ZIP/Postal code |
55905 |
Country |
USA |
|
|
Platform ID |
GPL21290 |
Series (1) |
GSE125577 |
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta |
|
Relations |
BioSample |
SAMN10805305 |
SRA |
SRX5286889 |